# When excluding anti-Jkb during antibody identification, a nonreactive result with which panel cell provides the most reliable rule-out?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=729649  
> language: ko  
> subject: Blood Banking · 수혈의학

## 문제

When excluding anti-Jkb during antibody identification, a nonreactive result with which panel cell provides the most reliable rule-out?

## 보기

1. Jk(a+b+)
2. Jk(a-b+) **✔ 정답**
3. Jk(a+b-)
4. Jk(a-b-)

**정답: 2**

## 해설

Kidd antibodies show dosage, reacting more strongly with cells homozygous for the antigen, so a rule-out should use a cell with a double dose of Jkb, the Jk(a-b+) phenotype. A weak anti-Jkb may miss heterozygous Jk(a+b+) cells, and Jk(a+b-) or Jk(a-b-) cells lack Jkb entirely and cannot exclude it.

## 같은 주제 문제

- [A pretransfusion antibody screen is positive with both screening cells, but the patient's …](https://mymerci.kr/pages/nclex_q.php?qn_id=471837)
- [A previously transfused patient has a negative antibody screen, but one of three donor uni…](https://mymerci.kr/pages/nclex_q.php?qn_id=568477)
- [An antibody identification panel shows reactivity only with cells positive for the K antig…](https://mymerci.kr/pages/nclex_q.php?qn_id=568478)
- [A patient has anti-K and anti-Jka. If approximately 91 percent of donors are K negative an…](https://mymerci.kr/pages/nclex_q.php?qn_id=568481)
- [Pretreating panel cells with ficin or papain typically enhances reactivity of which antibo…](https://mymerci.kr/pages/nclex_q.php?qn_id=729642)
- [A patient with multiple myeloma receiving daratumumab (anti-CD38) has weak panreactivity w…](https://mymerci.kr/pages/nclex_q.php?qn_id=729643)
- [An antibody panel tested by PEG-IAT gives these results (autocontrol negative). Cell 1: D+…](https://mymerci.kr/pages/nclex_q.php?qn_id=729650)
- [A hospital uses a validated computer (electronic) crossmatch. Which patient finding makes …](https://mymerci.kr/pages/nclex_q.php?qn_id=729661)

---

More free questions: [기출·모의문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._

